Published Date: 09 Dec 2024
Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half
Read Full News1.
Cancer patients want financial screening early in care, study finds
2.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
3.
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances
4.
A new blood test greatly increases the ability to detect cancer.
5.
Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?
1.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
2.
Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape
3.
Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control
4.
Seeing the Unseen: Examining Chancroid Through Images
5.
Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation